• Monica Healthcare

  Participated · Equity · Feb 2015

  Monica Healthcare specializes in wireless healthcare technology, providing wearable medical devices that monitor fetal and maternal well-being. Its AN24 product is an FDA-approved wireless fetal-maternal monitor used during labour and sold in the USA, Europe, Brazil, Russia, India and China. The AN24 system is used to monitor the delivery of over 100,000 babies every year. The company’s patented technology passively acquires electrophysiological signals from electrodes on the maternal abdomen and extracts fetal heart rate, maternal heart rate, uterine activity and fetal ECG morphology parameters in real time. Monica plans to use the recent funding and a Nottingham Technology Grant to expand operations and to underpin manufacture and launch of a second-generation FDA-cleared wireless fetal monitoring product. Founded in May 2005 following 15 years of research at the University of Nottingham, the company is led by CEO Dr Carl Barratt.

• TeraView

  Led · Equity · Feb 2012

  TeraView is a Cambridge, UK-based provider of Terahertz systems and solutions that applies Terahertz light for imaging and spectroscopy. Its proprietary platform uses the Terahertz spectrum between light and radio waves to deliver non-invasive, non-destructive three-dimensional structural and chemical information. Core applications include detection of faults and quality variations in semiconductor integrated circuits, with additional uses demonstrated for detecting concealed weapons/explosives, analysing tablet and capsule contents in pharmaceuticals, medical imaging of cancer, and industrial inspection. The company was spun out from the Toshiba Cambridge Research Laboratory in April 2001 and is led by CEO Don Arnone. TeraView raised $5.5m in funding in this round. The company intends to use the capital to increase sales and marketing efforts in Asia, accelerate product development in its semiconductor inspection market, and enhance support and collaborations with existing customers.

• Microvisk Technologies

  Participated · Equity · Jan 2011

  Microvisk Technologies, based in St Asaph, Denbighshire, UK, develops a handheld system to monitor blood clotting for patients taking warfarin. Led by CEO John Curtis, the company has developed a MEMS-based medical diagnostic strip and the Smartstrip® device for at-home testing. It expects to launch Smartstrip in the UK this autumn and plans trials in the USA and Germany within six months, with launches in those countries anticipated to follow in 2012. Microvisk raised £6m in its third funding round and previously raised £4.5m in 2010. The new funds will be used to continue UK clinical trials, expand research and manufacturing facilities, and recruit additional scientists and manufacturing staff. Microvisk Technologies is developing a handheld system and a MEMS-based diagnostic strip called SmartStrip to let patients monitor blood clotting while taking Warfarin. The SmartStrip technology is based on a micro-electro-mechanical system originally created as a movement system for nano-robots. Microvisk intends the system to enable at-home testing similar to glucose testing for diabetics. The company will use the new capital to finalize product development and start the testing necessary to secure regulatory approval in Europe and the US. Microvisk is a spin-out from the Science and Technology Facilities Council and is based at St Asaph Business Park in Wales, UK. The company planned to launch the SmartStrip system onto the market in 2011. Microvisk Technologies develops a patented solid-state technology for point-of-care monitoring of blood coagulation for patients taking Warfarin. Its core product is the SmartStrip system, a completely solid-state technology used to assess clotting ability. The company planned to continue product development in 2010 and to launch the SmartStrip system in 2011. The technology targets the roughly 7 million people in the western world who use Warfarin. Microvisk was originally a spin-out of the Science and Technology Facilities Council and became an independent company in 2004. It is based at St. Asaph Business Park in Wales and received initial backing from Rainbow Seed Fund.

No current team members are available.